Skip to main content
Caplight Logo









PharmatrophiX

PharmatrophiX

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://pharmatrophix.com/

Last Round

Grant

Jan 5, 2016

Total Funding Raised

$2.88M

Company Overview

PharmatrophiX is a clinical-stage biopharmaceutical company that develops disease-modifying small molecule drugs targeting mechanisms underlying neurodegenerative disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small molecule drugsneurodegenerative diseasesvirtual biotechdrug discoveryclinical-stage biopharmaneurotrophin receptor modulatorsynaptic protectionAlzheimer's disease treatmentProgressive Supranuclear PalsyPSPcontract research organizationCROdrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PharmatrophiX Comparables

Compare PharmatrophiX with similar companies based on industry and business-model similarity.

PharmatrophiX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gismo Therapeutics
82%
Spinogenix, Inc.
81%
Priavoid
74%

PharmatrophiX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 5, 2016
VC RoundOct 6, 2014
GrantJul 1, 2013
DebtAug 29, 2012
GrantOct 1, 2009
Grant
Feb 1, 2008

Key People

Founding team and executive leadership

David Setboun

Chief Operating Officer

Executive Team

PharmatrophiX Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 34% MoM.

  • Jan 5, 2016

    $500K grant from Alzheimer's Drug Discovery Foundation

PharmatrophiX Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PharmatrophiX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PharmatrophiX's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range4
Year Founded2005
Last FundingJan 5, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?